Physician profile
Wigberto Soto
NPI 1982665477
$6,402.81
in general payments reported to CMS, 2019-2025
40 companies · $994 in 2025
The $994 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $437 · 2021: $792 · 2022: $1,277 · 2023: $1,170 · 2024: $1,118 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,282.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $905.89 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $615.39 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $548.92 | 2021-2025 | |
| Novo Nordisk INC | $478.09 | 2022-2024 | Wegovy |
| Biogen, INC. | $435.73 | 2024-2025 | Zurzuvae |
| Millicent US INC | $297.80 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $292.89 | 2020-2025 | |
| Evofem Biosciences, INC. | $278.28 | 2021-2025 | Phexxi, Solosec, Phexx |
| Lupin INC. | $242.22 | 2019-2021 | |
| Pfizer INC. | $228.66 | 2021-2025 | |
| Amgen INC. | $220.82 | 2024-2025 | Evenity |
| Davol INC. | $219.35 | 2022 | |
| Organon LLC | $145.51 | 2021-2025 | Nexplanon |
| Medtronic, INC. | $140.41 | 2023-2025 | Ligasure, Truclear |
| Lilly USA, LLC | $138.48 | 2025 | Zepbound |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $133.97 | 2022-2024 | Accrufer |
| Sage Therapeutics, LLC | $131.24 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $124.40 | 2019 | |
| Myovant Sciences INC. | $102.99 | 2021-2022 | |
| Coopersurgical, INC. | $87.61 | 2023-2025 | Wallach Cryosurgical Equipment, Paragard T 380a |
| Smith+Nephew, INC. | $80.90 | 2019 | |
| Merck Sharp & Dohme LLC | $68.74 | 2019-2022 | |
| Hologic Sales and Service, LLC | $58.87 | 2020-2024 | Aptima, Thinprep 2000 Processor |
| Aspira Women'S Health INC | $50.19 | 2022-2024 | Ova1 |
| Exeltis, USA INC. | $47.16 | 2021-2024 | Tyblume |
| Therapeuticsmd, INC. | $36.42 | 2019 | |
| Avanos Medical | $36.04 | 2023 | On-Q* Pump and Accessories |
| Pacira Pharmaceuticals Incorporated | $35.20 | 2019-2021 | |
| Avion Pharmaceuticals | $28.06 | 2021-2022 | |
| Scynexis, INC. | $25.56 | 2022 | |
| Aroa Biosurgery Incorporated | $24.50 | 2025 | |
| Mylan Pharmaceuticals INC. | $23.84 | 2022 | |
| Daiichi Sankyo INC. | $22.37 | 2020 | |
| Mission Pharmacal Company | $16.34 | 2023 | Citranatal |
| Allergan, INC. | $15.93 | 2020 | |
| Medicem INC. | $14.26 | 2020 | |
| Myriad Women'S Health, INC. | $13.49 | 2023 | Myrisk |
| Sumitomo Pharma America, INC. | $12.99 | 2023 | Myfembree |
| Ascend Therapeutics US, LLC | $12.02 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wigberto Soto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.